HAVCR2 and neoplasm: Combined blockade of BTLA, PD-1 and TIM-3 enhanced the proliferation and function of tumor-specific CD8+T cells, suggesting a role for BTLA in regulating T-cell exhaustion in advanced melanoma.11 Recently, another co-inhibitory receptor TIGIT was demonstrated in T-cell exhaustion.